Back to top
more

Biotechnology Ultra Sector Pro Fund, Service: (MF: BIPSX)

(NASDAQ Mutual Funds) As of Aug 28, 2026 05:47 PM ET

$50.98 USD

-2.85 (-5.29%)

Zacks MF Rank

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

5-Strong Sell of 5         5

View All Zacks Mutual Fund Rank #1's

Latest Performance as of Nov 30, 2019

Total Return %* Percentile Rank Objective
YTD 21.63 50
3 months 24.30 1
6 months 26.70 1
1 Year 5.14 77
3 Year 11.20 81
5 Year 0.86 96
10 Year 20.25 1

* Annual for three years and beyond.

Zacks Premium Research for BIPSX

Zacks MF Rank

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Strong Sell 5
MF Report

Mutual Funds Research & Tools

Search Similar Mutual Funds

Research similar Mutual Funds with higher ranks and performance ratings.

Mutual Funds Comparison View (minimum of 2)

Mutual Funds Screener

Narrow down the universe of 18,000+ funds we rank with our robust, yet easy-to-use mutual fund screeners. Select from up to 50 different data points to find the mutual funds that best Screen meet your unique criteria.

Portfolio Statistics

% Unrealized Gain 39.16
% Yield 0.00
% SEC Yield NA
Net Assets (Mil $) 11/30/2019 5.56
% Turnover 11/30/2019 23.00

Risk

3 Year 5 Year 10 Year
Beta 1.73 1.85 1.57
Alpha -8.96 -13.24 2.09
R Squared 0.52 0.52 0.45
Std. Dev. 28.93 30.79 28.93
Sharpe 0.48 0.15 3.00

Sector / Country Weightings

As of 11/30/2019 % of Portfolio
Health 38.21
Other 36.17
Services 17.10
Technology 6.63
Industrial Cyclical 1.89

Portfolio Holdings

Top Equity Holdings
(As of 7/31/2019)		 % of Portfolio Value (Mil$)
NA 21.98 36.82
AMGEN INC 11.45 19.18
ABBVIE INC 9.91 16.60
GILEAD SCIENCES INC 8.38 14.04
CELGENE CORP 6.52 10.92
NA 4.64 7.77
ILLUMINA INC 4.43 7.42
VERTEX PHARMACEUTICALS IN 4.29 7.19
ALEXION PHARMACEUTICALS I 2.56 4.28

Stock Holding % of Net Assets

As Of 7/31/2019
Total Issues 48
Avg. P/E 33.78
Avg. P/Book 5.60
Avg. EPS Growth 16.15
Avg. Market Value (Mil $) 58,421

Composition

% of Portfolio
Stocks 100.00
Foreign Stocks 0.00
Cash 0.00
Bonds 0.00
Foreign Bonds 0.00
Preferred 0.00
Convertible 0.00
Other 0.00
Foreign Hedged 0.00

Style Analysis

% of Portfolio
Large Growth 0.00
Large Value 10.82
Small Growth 17.75
Small Value 0.00
Foreign Stock 9.27
Emerging Market 0.00
Precious Metal 0.00
Intermediate Bond 23.56
Foreign Bond 0.00
High Yield Bond 0.00